West Pharmaceutical Services reported $268M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Align Technology ALGN:US USD 619.17M 68.39M
Atrion ATRI:US USD 20.83M 3.46M
Baxter International BAX:US USD 1.15B 310M
Becton, Dickinson and BDX:US USD 2.08B 9M
Catalent CTLT:US USD 258M 230M
Charles River Laboratories CRL:US USD 370.22M 13.5M
Cooper Companies COO:US USD 552.1M 19.6M
Dentsply International XRAY:US USD 508M 73M
Icu Medical ICUI:US USD 186.4M 18.8M
Insulet PODD:US USD 188.3M 2M
Integra Lifesciences IART:US USD 240.94M 13.6M
IQVIA Holdings Inc IQV:US USD 1.24B 31M
Johnson & Johnson JNJ:US USD 15.98B 134M
Medtronic MDT:US USD 5.11B 232M
Meridian Bioscience VIVO:US USD 33.99M 2.74M
Merit Medical Systems MMSI:US USD 128.57M 6.49M
Orasure Technologies OSUR:US USD 46.19M 18.61M
Repligen RGEN:US USD 114.23M 7.15M
Terumo 4543:JP JPY 105.36B 3.72B
West Pharmaceutical Services WST:US USD 268M 53.5M